Cure My Disease

Don't miss your cure!

 Log in / Sign up

Real-World dupilumab study aims to improve COPD Patients' daily lives

NCT ID NCT07052396

Recruiting now Disease control Sponsor: Sanofi Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 350 adults with uncontrolled COPD who are starting dupilumab, a medication that reduces lung inflammation. Researchers will track changes in quality of life and breathing symptoms over two years using simple questionnaires. The goal is to see how well the drug works outside of a controlled clinical setting.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Investigational Site Number: DE01

    RECRUITING

    Darmstadt, 64283, Germany

  • Investigational Site Number: DE02

    RECRUITING

    Berlin, 14163, Germany

  • Investigational Site Number: DE03

    RECRUITING

    Hamburg, 20354, Germany

  • Investigational Site Number: DE04

    RECRUITING

    Hamburg, 22459, Germany

  • Investigational Site Number: DE06

    RECRUITING

    Flensburg, 24937, Germany

  • Investigational Site Number: DE07

    RECRUITING

    Hohenstein-Ernstthal, 09337, Germany

  • Investigational Site Number: DE08

    RECRUITING

    Fürstenwalde, 15517, Germany

  • Investigational Site Number: DE09

    RECRUITING

    Erkelenz, 41812, Germany

  • Investigational Site Number: DE10

    RECRUITING

    Itzehoe, 25524, Germany

  • Investigational Site Number: DE13

    RECRUITING

    Bad Homburg, 61350, Germany

  • Investigational Site Number: DE14

    RECRUITING

    Markkleeberg, 04416, Germany

  • Investigational Site Number: DE18

    RECRUITING

    Auerbach, 08209, Germany

  • Investigational Site Number: DE19

    RECRUITING

    Berlin, 10717, Germany

  • Investigational Site Number: DE20

    RECRUITING

    Marburg, 35037, Germany

  • Investigational Site Number: DE21

    RECRUITING

    Augsburg, 86152, Germany

  • Investigational Site Number: DE24

    RECRUITING

    Kaiserslauten, 67655, Germany

  • Investigational Site Number: DE25

    RECRUITING

    Lüneburg, 21339, Germany

  • Investigational Site Number: DE29

    RECRUITING

    Burgwedel, 30938, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.